During the last session, Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s traded shares were 3.98 million, with the beta value of the company hitting 1.19. The 52-week high for the ADIL share is $3.00, that puts it down -1150.0 from that peak though still a striking 8.33% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $2.49M, and the average intraday trading volume over the past 10 days was 2.98 million shares, and the average trade volume was 984.32K shares over the past three months.
Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information
Adial Pharmaceuticals Inc (ADIL) registered a -0.67% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.67% in intraday trading to $0.24, hitting a weekly high. The stock’s 5-day price performance is -47.22%, and it has moved by -65.86% in 30 days. Based on these gigs, the overall price performance for the year is -81.76%. The short interest in Adial Pharmaceuticals Inc (NASDAQ:ADIL) is 0.13 million shares and it means that shorts have 0.08 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 34.05%. While earnings are projected to return 61.03% in 2025, the next five years will return 41.31% per annum.
ADIL Dividends
Adial Pharmaceuticals Inc is due to release its next quarterly earnings on 2025-May-14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders
Adial Pharmaceuticals Inc insiders own 1.05% of total outstanding shares while institutional holders control 6.59%, with the float percentage being 6.66%. UBS GROUP AG is the largest shareholder of the company, while 15.0 institutions own stock in it. As of 2024-06-30, the company held over 83605.0 shares (or 1.9988% of all shares), a total value of $96146.0 in shares.
The next largest institutional holding, with 48097.0 shares, is of MANCHESTER CAPITAL MANAGEMENT LLC’s that is approximately 1.1499% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $55312.0.
